Yubo International Biotech Ltd

YBGJ OTC CIK: 0000895464

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NY
Business Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE, BEIJING, F4, 00000
Mailing Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE, BEIJING, F4, 00000
Phone 86 (010) 6615-5141
Fiscal Year End 1231
EIN 113074326

Financial Overview

FY2025

$4.83M
Total Liabilities
-$1.95M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events January 16, 2026 View on SEC
10-Q Quarterly financial report November 14, 2025 View on SEC
10-Q Quarterly financial report August 13, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment July 25, 2025 View on SEC
4 Insider stock transaction report July 25, 2025 View on SEC
4 Insider stock transaction report July 25, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment July 25, 2025 View on SEC
8-K Current report of material events July 25, 2025 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) June 3, 2025 View on SEC

Annual Reports

10-K March 31, 2026
  • Operates in the high-growth stem cell technology and health product sector.
  • Manages the VIVCELL brand for endometrial stem cell storage.
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.